Low-mannose-binding lectin levels in susceptibility to neonatal sepsis in preterm neonates with fetal inflammatory response syndrome

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 23, Issue 9, 2010, Pages 1009-1013

  Ozdemir, Ozgur ^a   Dinleyici, Ener Cagri ^a   Tekin, Neslihan ^a   Colak, Omer ^a   Aksit, M Arif ^a  

^a ESKISEHIR OSMANGAZI UNIVERSITY   (Turkey)

Author keywords

Fetal inflammation; IL 6; MBL; preterm delivery; TNF alfa

Indexed keywords

INTERLEUKIN 6; MANNOSE BINDING LECTIN; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BACTERIUM CULTURE; BIRTH WEIGHT; CLINICAL ARTICLE; COAGULASE NEGATIVE STAPHYLOCOCCUS; CONTROLLED STUDY; ESCHERICHIA COLI; FEMALE; FETAL INFLAMMATORY RESPONSE SYNDROME; FETUS DISEASE; GESTATIONAL AGE; HUMAN; INFECTION SENSITIVITY; KLEBSIELLA PNEUMONIAE; MALE; NEWBORN; NEWBORN SEPSIS; PREGNANCY; PREMATURITY; PRIORITY JOURNAL; PROTEIN DEFICIENCY; RISK ASSESSMENT; UMBILICAL CORD BLOOD;

CASE-CONTROL STUDIES; DISEASE SUSCEPTIBILITY; FEMALE; FETAL BLOOD; FOLLOW-UP STUDIES; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; MALE; MANNOSE-BINDING LECTIN; SEPSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 77955910721     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.3109/14767050903551418     Document Type: Article

References (27)

1. Slattery MM, Morrison JJ. Preterm delivery. Lancet 2002;360:1489-1497.
2. Gotsch F, Romero R, Kusanovic JP, et al. The fetal inflammatory response syndrome. Clin Obstet Gynecol 2007;50:652-683.
3. Stoll BJ, Hansen NI, Higgins RD, et al. Very low birth weight preterm infants with early onset neonatal sepsis: the predominance of gram-negative infections continues in the National Institute of Child Health and Human Development Neonatal Research Network, 2002-2003. Pediatr Infect Dis J 2005;24:635-639.
4. de Benedetti F, Auriti C, D'Urbano LE, et al. Low serum levels of mannose binding lectin are a risk factor for neonatal sepsis. Pediatr Res 2007;61:325-328.
5. Turner MW. The role of mannose-binding lectin in health and disease. Mol Immunol 2003;40:423-429.
6. Gadjeva M, Takahashi K, Thiel S. Mannan-binding lectin - a soluble pattern recognition molecule. Mol Immunol 2004; 41:113-121. (Pubitemid 38678615)
7. Kilpatrick DC. Mannan-binding lectin: clinical significance and applications. Biochim Biophys Acta 2002;1572:401-413.
8. Frakking FN, Brouwer N, van Eijkelenburg NK, et al. Low mannose-binding lectin (MBL) levels in neonates with pneumonia and sepsis. Clin Exp Immunol 2007;150: 255-262.
9. Dzwonek AB, Neth OW, Thiébaut R, et al. The role of mannose-binding lectin in susceptibility to infection in preterm neonates. Pediatr Res 2008;63:680-685.
10. Cedzynski M, Szemraj J, Swierzko AS, et al. Mannan-binding lectin insufficiency in children with recurrent infections of the respiratory system. Clin Exp Immunol 2004;136:304-311.
11. Ahrens P, Kattner E, Köhler B, et al. Mutations of genes involved in the innate immune system as predictors of sepsis in very low birth weight infants. Pediatr Res 2004;55: 652-656.
12. Neth O, Hann I, Turner MW, Klein NJ. Deficiency of mannose binding lectin and burden of infection in children with malignancy: a prospective study. Lancet 2001;358:614-618.
13. Summerfield JA, Sumiya M, Levin M, Turner MW. Association of mutations in mannose binding protein gene with childhood infection in consecutive hospital series. BMJ 1997; 314:1229-1232.
14. Koch A, Melbye M, Sorensen P. Acute respiratory tract infections and mannose-binding lectin insufficiency during early childhood. JAMA 2001;285:1316-1321.
15. Fidler KJ, Wilson P, Davies JC, Turner MW, Peters MJ, Klein NJ. Increased incidence and severity of the systemic inflammatory response syndrome in patients deficient in mannose-binding lectin. Intens Care Med 2004;30:1438-1445.
16. Eisen DP, Minchinton RM. Impact of mannose-binding lectin on susceptibility to infectious diseases. Clin Infect Dis 2003;37:1496-1505.
17. Frakking FN, Brouwer N, Zweers D, et al. High prevalence of mannose-binding lectin (MBL) deficiency in premature neonates. Clin Exp Immunol 2006;145:5-12.
18. Terai I, Kobayashi K. Perinatal changes in serum mannosebinding protein (MBP) levels. Immunol Lett 1993;38:185-187.
19. Thiel S, Bjerke T, Hansen D, Poulsen LK, Schiotz PO, Jensenius JC. Ontogeny of human mannan-binding protein, a lectin of the innate immune system. Pediatr Allergy Immunol 1995;6:20-23.
20. Lau YL, Chan SY, Turner MW, Fong J, Karlberg J. Mannosebinding protein in preterm infants: developmental profile and clinical significance. Clin Exp Immunol 1995; 102:649-654.
21. Hilgendorff A, Schmidt R, Bohnert A, Merz C, Bein G, Gortner L. Host defence lectins in preterm neonates. Acta Paediatr 2005;94:794-799.
22. Neth O, Jack DL, Johnson M, Klein NJ, Turner MW. Enhancement of complement activation and opsonophagocytosis by complexes of mannose-binding lectin with mannosebinding lectin-associated serine protease after binding to Staphylococcus aureus.J Immunol 2002;169:4430-4436.
23. Gomez R, Romero R, Ghezzi F, Yoon BH, Mazor M, Berry SM. Fetal inflammatory response syndrome. Am J Obstet Gynecol 1998;179:194-202.
24. Casanova JL, Abel L. Human mannose-binding lectin in immunity: friend, foe, or both? J Exp Med 2004;199:1295-1299.
25. Kielgast S, Thiel S, Henriksen TB, Bjerke T, Olsen J, Jensenius JC. Umbilical cord mannan-binding lectin and infections in early childhood. Scand J Immunol 2003;57:167-172.
26. Jack DL, Read RC, Tenner AJ, Frosch M, Turner MW, Klein NJ. Mannose-binding lectin regulates the inflammatory response of human professional phagocytes to Neisseria meningitidis Serogroup B. J Infect Dis 2001;1184:1152-1162.
27. Valdimarsson H, Vikingsdottir T, Bang P, et al. Human plasma-derived mannose-binding lectin: a phase I safety and pharmacokinetic study. Scand J Immunol 2004;59:97-102.